EASY BIO,Inc. (353810) Fair Value & Analysis
Consumer Non-Cyclicals · KR · Market cap 202B KRW
Fair value as of: Jul 21, 2026
From 24 valuation models · updated 21 days ago
Fair value updated Jul 21, 2026, revised from 16,375 KRW to 17,633 KRW (+7.7%) since Jun 25, 2026. Share price +4.0% over the past month.
A solid business, screening 172% undervalued on our models.
What matters now
- The price is below even our cautious bear case (12,952 KRW). The market is more pessimistic than our downside scenario.
- The model range is unusually wide (12,952 KRW to 49,972 KRW). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid quality (63/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range 2,737 KRW – 8,060 KRW · fair‑value band 12,952 KRW – 49,972 KRW · the 6,480 KRW price screens below the 17,633 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
EASY BIO,Inc. (353810) currently trades at 6,480 KRW, while our model-based Fair Value estimate is 17,633 KRW, implying the stock looks roughly 172.1% undervalued today. The Quality Score stands at 63/100 (solid quality), in the Consumer Non-Cyclicals sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, EASY BIO,Inc. generated revenue of 150B KRW at a net margin of 6.3%. Revenue grew 23.5% year over year. Net debt stands at 91.4B KRW. Fundamentals as of Jul 21, 2026
Our scenario range runs from 12,952 KRW (bear case) to 49,972 KRW (bull case); at 6,480 KRW, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 22% below its 52-week high and 38% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at 7% fair-value upside, at 172%, 353810 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth Earnings (40,834 KRW) versus Asset-Based (2,306 KRW). Highest evidence: Growth DCF (80).
Notify me when 353810 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 63 · Market factors (momentum, volatility) 45
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
EASY BIO,Inc. provides specialized piglet feed and feed additives solutions in South Korea and internationally. The company was founded in 2020 and is based in Seoul, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
EASY BIO,Inc. reported revenue of 477B KRW in FY2025 versus 129B KRW in FY2021, a compound +38.5%/yr. Reported net income was 27.8B KRW in FY2025, compounding +26.4%/yr from FY2021.
Watch 353810: get an alert when its fair value changes →
Peer Group
Food & Tobacco · 19 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Food & Tobacco stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| FB FB | 49.00 PHP | 49.03 PHP | +0% |
| URC URC | 61.20 PHP | 47.86 PHP | -22% |
| CNPF CNPF | 32.50 PHP | 64.84 PHP | +100% |
| 540743 540743 | ₹556.65 | ₹616.73 | +11% |
| DNL DNL | 3.64 PHP | 3.43 PHP | -6% |
| RFM RFM | 5.41 PHP | 8.87 PHP | +64% |
| AXLM AXLM | 2.70 PHP | 2.89 PHP | +7% |
| Helixmith Co 084990 | 3,315 KRW | 823.10 KRW | -75% |
| LFM LFM | 26.60 PHP | 7.12 PHP | -73% |
| MSC Co 009780 | 6,020 KRW | 22,224 KRW | +269% |
Compare EASY BIO,Inc. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is EASY BIO,Inc. (353810) overvalued or undervalued?
What is the fair value of 353810?
What is the quality score of 353810?
What is the revenue of EASY BIO,Inc. (353810)?
What is the net profit margin of 353810?
Does EASY BIO,Inc. pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track EASY BIO,Inc. and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.